Navy General Hospital
Beijing, 100048, China
Location status: Recruiting
NCT Number: NCT04157569
This study will monitor CtDNA After Chemotherapy in Elderly Patients With AL
Interested in participating?
Request Info60 year–100 year
All sexes
Observational
Beijing, 100048, China
Location status: Recruiting
This study will use droplet digital PCR (ddPCR) method to quantify peripheral blood plasma mutant allele frequency (MAF) in elderly acute leukemia patients after chemotherapy to evaluate the clinical value of CtDNA .
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: through study completion, an average of 1 year
cumulative incidence of relapse
Time frame: through study completion, an average of 2 years
overall survival
Interested in participating?
Request InfoNavy General Hospital, Beijing
Other
Monitoring Circulating Tumor DNA After Chemotherapy in Elderly Patients With Acute Leukemia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04811560
Acute Leukemia
Duarte, California, United States
View Trial DetailsNCT04224974
Acute Leukemia
Hamilton, Ontario, Canada
View Trial DetailsNCT06907797
Acute Leukemia, Hematologic Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT07573111
Acute Leukemia, Bone Marrow Diseases
Palo Alto, California, United States
View Trial Details